Naproxen. Proceedings from an International Medical Symposium presented by Syntex Corporation 7-8 May 1973, Geneva, Switzerland.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics; D000818:Animals; D000893:Anti-Inflammatory Agents; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005260:Female; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D008738:Methyl Ethers; D008875:Middle Aged; D009281:Naphthalenes; D010003:Osteoarthritis / Q000188:drug therapy; D010149:Postoperative Pain / Q000188:drug therapy; D011247:Pregnancy; D011422:Propionates; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates; D001241:Aspirin; D007213:Indomethacin